Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: Efficacy results with a median follow-up of 4 years.

Reviewer: Christopher Dolinsky, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 16 de mayo del 2005

Translation for this article does not exist

Blogs

Living with a Rare Cancer
by Bob Riter
March 31, 2016

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016